Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body
|
September 3, 2025
Conscience: A Brief History
Jose A Bufill, Xavier Symons
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2020
ASCO Voices 2020
Daniel Rayson, Jose A Bufill, Julia Close, et al.
The Oncologist
|
January 3, 2012
Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101
E Gabriela Chiorean, Rashmi Ramasubbaiah, Menggang Yu, et al.
Case Reports in Critical Care
|
August 25, 2023
Type B Lactic Acidosis in a Patient with Mantle Cell Lymphoma
Ikemsinachi C Nzenwa, Margaret Berquist, Toby J Brenner, et al.
Breast Cancer Research and Treatment
|
February 19, 2018
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
Lynne I Wagner, Fengmin Zhao, Paul E Goss, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 9, 2018
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC
Jonathan W Riess, David R Gandara, Garrett M Frampton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2017
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling
Alexa B Schrock, Shuyu D Li, Garrett M Frampton, et al.
Cancer Discovery
|
May 15, 2015
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors
Garrett M Frampton, Siraj M Ali, Mark Rosenzweig, et al.
Cancer Discovery
|
May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body
|
September 3, 2025
Conscience: A Brief History
Jose A Bufill, Xavier Symons
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2020
ASCO Voices 2020
Daniel Rayson, Jose A Bufill, Julia Close, et al.
The Oncologist
|
January 3, 2012
Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101
E Gabriela Chiorean, Rashmi Ramasubbaiah, Menggang Yu, et al.
Case Reports in Critical Care
|
August 25, 2023
Type B Lactic Acidosis in a Patient with Mantle Cell Lymphoma
Ikemsinachi C Nzenwa, Margaret Berquist, Toby J Brenner, et al.
Breast Cancer Research and Treatment
|
February 19, 2018
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
Lynne I Wagner, Fengmin Zhao, Paul E Goss, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 9, 2018
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC
Jonathan W Riess, David R Gandara, Garrett M Frampton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2017
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling
Alexa B Schrock, Shuyu D Li, Garrett M Frampton, et al.
Cancer Discovery
|
May 15, 2015
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors
Garrett M Frampton, Siraj M Ali, Mark Rosenzweig, et al.
Cancer Discovery
|
May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Page
of 1